New York State Common Retirement Fund Biotechnology

New York State Common Retirement Fund

$68.1 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$119B	$168 Million 0.25% of portfolio	345,796	Q1 2025 Reduced 4.56%
REGN Regeneron Pharmaceuticals, Inc.	$59B	$82.8 Million 0.12% of portfolio	130,540	Q1 2025 Reduced 4.98%
VCEL Vericel Corp	$1.71B	$38.5 Million 0.06% of portfolio	862,331	Q1 2025 Added 0.87%
ARGX Argenx Se	$31.7B	$38 Million 0.06% of portfolio	64,250	Q1 2025 Added 1.13%
ASND Ascendis Pharma A/S	$9.89B	$31.9 Million 0.05% of portfolio	204,482	Q4 2024 Added 14.03%
TECH Bio Techne Corp	$2.09B	$31.6 Million 0.05% of portfolio	539,258	Q1 2025 Reduced 0.88%
INSM Insmed Inc	$14.1B	$27.1 Million 0.04% of portfolio	355,722	Q1 2025 Added 11.95%
VCYT Veracyte, Inc.	$1.73B	$19.8 Million 0.03% of portfolio	667,329	Q1 2025 Reduced 15.09%
HALO Halozyme Therapeutics, Inc.	$8.05B	$19.1 Million 0.03% of portfolio	300,001	Q1 2025 Reduced 18.48%
ALNY Alnylam Pharmaceuticals, Inc.	$39.9B	$17.4 Million 0.03% of portfolio	64,272	Q1 2025 Reduced 11.02%
SWTX Spring Works Therapeutics, Inc.	$2.93B	$16.1 Million 0.02% of portfolio	365,860	Q1 2025 Added 0.49%
MDGL Madrigal Pharmaceuticals, Inc.	$5.96B	$14.8 Million 0.02% of portfolio	44,771	Q1 2025 Added 9.69%
MIRM Mirum Pharmaceuticals, Inc.	$1.94B	$11.7 Million 0.02% of portfolio	260,366	Q1 2025 Added 14.02%
TGTX Tg Therapeutics, Inc.	$5.69B	$11.6 Million 0.02% of portfolio	293,279	Q1 2025 Reduced 2.04%
BNTX Bio N Tech Se	$26.9B	$11.4 Million 0.02% of portfolio	125,296	Q4 2024 Reduced 42.54%
LGND Ligand Pharmaceuticals Inc	$2.32B	$10.5 Million 0.02% of portfolio	99,537	Q1 2025 Added 7.7%
MRNA Moderna, Inc.	$12.6B	$10.3 Million 0.02% of portfolio	364,767	Q1 2025 Reduced 8.38%
UTHR United Therapeutics Corp	$13.5B	$10.2 Million 0.02% of portfolio	33,215	Q1 2025 Reduced 4.6%
SRPT Sarepta Therapeutics, Inc.	$1.92B	$8.27 Million 0.01% of portfolio	129,562	Q1 2025 Reduced 2.85%
RNA Avidity Biosciences, Inc.	$1.77B	$8.04 Million 0.01% of portfolio	272,279	Q1 2025 Added 47.33%
BMRN Biomarin Pharmaceutical Inc	$10.8B	$6.54 Million 0.01% of portfolio	92,497	Q1 2025 Reduced 1.23%
JAZZ Jazz Pharmaceuticals PLC	$7.2B	$6.26 Million 0.01% of portfolio	50,396	Q1 2025 Reduced 7.14%
IMCR Immunocore Holdings PLC	$1.59B	$6.02 Million 0.01% of portfolio	202,806	Q3 2024 Reduced 12.81%
EXEL Exelixis, Inc.	$14.4B	$5.96 Million 0.01% of portfolio	161,457	Q1 2025 Added 2.67%
RPRX Royalty Pharma PLC	$15.5B	$5.89 Million 0.01% of portfolio	189,293	Q1 2025 Reduced 29.05%
ADMA Adma Biologics, Inc.	$3.45B	$5.44 Million 0.01% of portfolio	274,419	Q1 2025 Added 12.46%
IDYA Ideaya Biosciences, Inc.	$1.06B	$5.42 Million 0.01% of portfolio	331,072	Q3 2024 Reduced 14.57%
PCVX Vaxcyte, Inc.	$2.22B	$5.19 Million 0.01% of portfolio	137,440	Q1 2025 Added 190.6%
XENE Xenon Pharmaceuticals Inc.	$2B	$4.78 Million 0.01% of portfolio	142,372	Q1 2025 Added 7.43%
INCY Incyte Corp	$15.3B	$4.7 Million 0.01% of portfolio	77,641	Q1 2025 Reduced 3.72%
CRNX Crinetics Pharmaceuticals, Inc.	$1.77B	$4.63 Million 0.01% of portfolio	137,918	Q1 2025 Reduced 11.26%
KRYS Krystal Biotech, Inc.	$3.85B	$4.22 Million 0.01% of portfolio	23,382	Q4 2024 Reduced 9.59%
BGNE Bei Gene, Ltd.	$23.5B	$4.12 Million 0.01% of portfolio	15,149	Q1 2025 Added 24.45%
CORT Corcept Therapeutics Inc	$7.83B	$4.06 Million 0.01% of portfolio	35,563	Q1 2025 Reduced 9.8%
NVO Novo Nordisk A S	$147B	$4.02 Million 0.01% of portfolio	57,939	Q1 2025 Reduced 55.85%
AXSM Axsome Therapeutics, Inc.	$4.81B	$3.92 Million 0.01% of portfolio	33,581	Q1 2025 Added 49.31%
HRTX Heron Therapeutics, Inc.	$238M	$3.86 Million 0.01% of portfolio	1,752,924	Q1 2025 Added 32.7%
IOVA Iovance Biotherapeutics, Inc.	$369M	$3.73 Million 0.01% of portfolio	1,121,417	Q4 2024 Reduced 8.1%
BBIO Bridge Bio Pharma, Inc.	$6.93B	$2.95 Million 0.0% of portfolio	85,354	Q1 2025 Added 63.59%
VKTX Viking Therapeutics, Inc.	$2.46B	$2.87 Million 0.0% of portfolio	118,898	Q4 2024 Reduced 2.86%
IONS Ionis Pharmaceuticals Inc	$5.99B	$2.36 Million 0.0% of portfolio	78,261	Q1 2025 Reduced 7.12%
INVA Innoviva, Inc.	$1.39B	$2.28 Million 0.0% of portfolio	125,892	Q3 2024 Reduced 16.57%
RARE Ultragenyx Pharmaceutical Inc.	$1.92B	$2.23 Million 0.0% of portfolio	61,667	Q1 2025 Added 5.29%
CPRX Catalyst Pharmaceuticals, Inc.	$2.21B	$2.23 Million 0.0% of portfolio	92,001	Q1 2025 Added 155.32%
TARS Tarsus Pharmaceuticals, Inc.	$1.1B	$2.21 Million 0.0% of portfolio	43,004	Q4 2024 Reduced 3.59%
HRMY Harmony Biosciences Holdings, Inc.	$2.16B	$2.2 Million 0.0% of portfolio	66,171	Q1 2025 Added 6.94%
RVMD Revolution Medicines, Inc.	$3.42B	$2.13 Million 0.0% of portfolio	60,322	Q1 2025 Reduced 5.16%
FOLD Amicus Therapeutics, Inc.	$1.76B	$2.09 Million 0.0% of portfolio	256,484	Q1 2025 Reduced 72.8%
LEGN Legend Biotech Corp	$7.05B	$2.01 Million 0.0% of portfolio	59,276	Q4 2024 Added 196.08%
ROIV Roivant Sciences Ltd.	$8.21B	$1.93 Million 0.0% of portfolio	191,393	Q1 2025 Reduced 12.92%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.